Related Experiment Video
Updated: Jul 1, 2026

Spatial Measurements of Perfusion, Interstitial Fluid Pressure and Liposomes Accumulation in Solid Tumors
Published on: August 18, 2016
Drug penetration in solid tumors: influence of drug size and capillary architecture
Hooman Salavati1,2,3, Massimo Lai4, Cesar Pichardo-Almarza4
1Department of Human Structure and Repair, Ghent University, Ghent, Belgium.
Introduction:
Macromolecular and nanoparticulate drug carriers are increasingly important in oncology due to improved targeting and reduced systemic toxicity; however, their delivery to solid tumors is often limited by size-dependent transport barriers.
Methods:
We present a computational modeling framework that couples microvascular blood flow, transvascular exchange, interstitial fluid flow, and macromolecule transport to investigate the interplay between drug properties, particularly particle size, and tumor capillary structural characteristics. A stochastic capillary network generation algorithm was developed to produce realistic microvascular networks with heterogeneous vessel radius, branching patterns, and permeability properties.
Results:
Simulations show an inverse relationship between particle size and penetration and quantify how pore radius and pore area fraction modulate extravasation and tissue dispersion.
Conclusions:
Overall, the framework may serve as a prototype in silico tool for drug formulation design, supporting the selection of molecular formats and sizes that distribute more efficiently within tumors under tumor-specific biophysical constraints.
Insights
Particle size significantly impacts drug delivery to solid tumors. Smaller particles penetrate tumors more effectively, guiding better drug formulation for enhanced cancer treatment efficacy.
Area of Science:
- Oncology
- Biophysics
- Computational Biology
Background:
- Macromolecular and nanoparticulate drug carriers are crucial in oncology for targeted therapy and reduced toxicity.
- Solid tumor drug delivery is often hindered by size-dependent transport barriers within the tumor microenvironment.
Purpose of the Study:
- To develop a computational framework modeling drug carrier transport in solid tumors.
- To investigate the influence of drug carrier size and tumor capillary characteristics on delivery efficiency.
Main Methods:
- Coupled computational modeling of blood flow, transvascular exchange, interstitial fluid flow, and macromolecule transport.
- Stochastic algorithm for generating realistic tumor microvascular networks with heterogeneous properties.
Main Results:
- An inverse relationship between particle size and tumor penetration was observed.
- Quantified the impact of pore radius and area fraction on drug extravasation and tissue dispersion.
Conclusions:
- The developed framework serves as an in silico tool for optimizing drug formulation design.
- Enables selection of optimal molecular formats and sizes for efficient tumor drug distribution based on biophysical constraints.
Related Concept Videos
Factors Affecting Drug Distribution: Tissue Permeability
Small molecules with a molecular weight below 500 to 600 Daltons can easily pass through the capillary membrane, gaining access to different tissues. Larger...
Bioavailability Enhancement: Drug Permeability Enhancement
Modified-Release Drug Delivery Systems: Site-Targeted
Drug Absorption: Overview
When drugs are injected intravenously, they directly enter the systemic circulation. Alternatively, orally administered drugs navigate through the gastrointestinal (GI) tract.
Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
Factors Affecting Drug Distribution: Physiological Barriers
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...

